Presentations from November 6 & 7, 2024
KEYNOTE: The Precision Patient: My Experience with Rare Cancer and Clinical Trials
- Allen Chankowsky, Acclaimed Author, International Speaker, and resilient 33-year survivor of a rare form of stage-4 Androgen Receptor positive cancer
Advancing Randomized Controlled Trials (RCTs) in Ontario and Canada
- Dr. PJ Devereaux, Director, Division of Perioperative Care, and Professor, Departments of Health Research Methods, Evidence, and Impact and Medicine, McMaster University; Associate Deputy Director and Senior Scientist, Population Health Research Institutes
The Ambitious Vision of Ontario’s Clinical Trials Leadership Table
- Dr. Bradly Wouters, Executive Vice President, Science and Research, University Health Network
Ontario’s Hard Pivot to Life Sciences
- Dr. Jason Field, President and CEO of Life Sciences Ontario
Community Hospitals: Essential Contributors to Ontario’s Evolving Clinical Trials Network
- Carley McPherson, Director of Research, Lakeridge Hospital
Clinical Trials at the Canadian Institutes of Health Research
Dr. Megan Bettle, Executive Director, Clinical Trials, Canadian Institutes of Health Research
Reducing Barriers: Equity and Diversity in Clinical Trials
- Moderator: Michelle Audoin, Patient and Family Advisory Council, Ontario Institute of Cancer Research
Trust Matters: Partnering with the New Immigrant Community in Clinical Research
- Munaza Jamil, Chair, N2 Public Engagement Committee
Remuneration and Recognition of Patient Partners in Clinical Trials
- Dr. Stuart Nicholls, Strategy for Patient-Oriented Research Program Facilitator, Office for Patient Engagement in Research Activities (OPERA), The Ottawa Hospital Research Institute’s Methods Centre
Improving Justice, Equity, Diversity, and Inclusion in Pediatric Research by Assessing and Addressing Language Barriers
- Dr. Quynh Doan, Senior Executive Director, Associate Dean, Research, Congdon Family Hospital Chair in Research at BC Children’s Hospital, Clinician Scientist, Pediatric Emergency Medicine
Canadians Want More Options for Decentralized and Hybridized Clinical Trials
- Donna Lillie, CTO College of Lived Experience Member
- Mike Lapenna, CTO College of Lived Experience Member
One Year Later: Progress Report on Advanced Consent in Stroke Trials
- Michel Shamy MD MA FRCPC, Attending Neurologist, The Ottawa Hospital; Scientist, Ottawa Hospital Research Institute; Associate Professor, Departments of Medicine & Epidemiology, University of Ottawa; Lead, Ethics & Humanities in Medicine, University of Ottawa
KEYNOTE: What Does Indigenous Cultural Safety Have to Do With ME?
- Dr. Janet Smylie, Family Physician and Research Scientist, Unity Health Toronto; Professor, University of Toronto (Dalla Lana School of Public Health and Department of Family and Community Medicine); Tier 1 Canada Research Chair in Advancing Generative Health Services for Indigenous Populations in Canada